The battle has begun! For the first matchup of the Royal Lymphoma Rumble at #PPLC24 Dr Kerry Savage from University of British Columbia edges out Dr Swaminathan Iyer from MD Anderson Cancer Center for the belt in favor of BV-CHP in CD30+ non-ALCL T-cell lymphoma!

Winner and still the champ! Dr. Kerry Savage! #PPLC24

Winner and still champ! Dr. Jeremy Abramson!!

Delighted to invite you the inaugural Pan Pacific Leukemia Conference (July 2025) along with my colleagues Vijaya R Bhatt, MBBS, MS Matt Lunning D.O. Julie Vose We will cover AML, MDS, ALL, CML, MPN and CLL Please join us next year.

The July issue of ONCOLOGY is available online. Checkout articles on atypical lung NETs, fruquintinib use in CRC, and the recent approval of liso-cel in MCL. Julie Vose MUSC Hollings Cancer Center Michael Wang, MD MD Anderson Cancer Center Laura Goff cancernetwork.com/journals/oncol…

It is all about paying it forward to the next generation of Hem/Onc Physicians!

Such an honor to teach and learn from the oncology clinical researchers of tomorrow ASCO AACR Methods in Clinical Research!

ASCO AACR Methods in Clinical Cancer Research 2024- it is so much fun interacting with this group of talented scholars and faculty members! Julie Vose

A great honor to be ASCO AACR Methods in Clinical Cancer Research with great UNMC Heme Onc Faculty

Susan Blumel is the recipient of the Gold U Award for her impact on clinical cancer research! “Susan is a thoughtful and caring research nurse who is a wonderful role model for all research personnel,” Dr. Julie Vose said. unmc.edu/newsroom/2024/…

Julie M. Vose, MD, MBA, discusses results with epcoritamab from the follicular lymphoma cycle 1 optimization cohort of the phase 1/2 EPCORE NHL-1 trial. @drjulievose University of Nebraska Medical Center #lymsm onclive.com/view/epcoritam…

Wonderful example of high quality research that benefits our patients!

Exciting future at UNMC/Nebraska Medicine!

New publication 📝 Results from the phase II EPCORE NHL-1 trial published in The Lancet Haematology provide new insights for follicular #lymphoma, see: loom.ly/MRuDISM #lymsm #FollicularLymphoma #MedNews #MedEd

Championship athletics partners with world-class medicine. Read more about the partnership here: unmc.edu/newsroom/2024/… There is no place like Nebraska. #GBR

A new study published in The Lancet Haematology found that epcoritamab was associated with an ORR of 82% in patients with R/R follicular #lymphoma📝  More news: lymphomahub.com #lymsm #MedNews #MedEd

Don't miss this opportunity to nominate the 2024 Woman Oncologist of the Year or Rising Star award recipient! (loom.ly/P2HEowA) Register for #LEAD2024 (loom.ly/GvkX9fk) to hear the winners announced live from San Diego. #womenleadersinoncology #heforshe

“A number of trials are combining bispecific antibodies with chemotherapy or chemoimmunotherapy for upfront settings, as well as focusing on dose-limiting or time-limiting therapy in follicular lymphoma,” -Julie Vose of Nebraska Medicine targetedonc.com/view/exploring…

#LEAD2024 is taking place on September 27-28, or join us virtually! Our agenda focuses on empowering women leaders in the #hematology and #oncology spaces by providing essential clinical updates, career development, and networking. Register today: loom.ly/KJnoJb0

Great work team!! Nebraska Medicine University of Nebraska Medical Center